Ontvang nu dagelijks onze kooptips!
word abonnee
sluiten ✕
eri09 schreef op 5 april 2018 01:39 :
[...]
hmm Canopy met een gemiddelde van 16,49 hoe dan want de koers is sinds 6-11-2017 niet meer onder de 16,5 geweest dus hoe heb jij dan van 23,16 kunnen middelen naar 16,49 ( of iets via short gecompenseerd ? )
Door telkens te verkopen en dan €1,20 lager terug te kopen en dat herhalen. Met die 20ct dekte ik de orderkosten af en die €1 ging dan af van mijn gemiddelde prijs per aandeel. Overigens is de koers gisteren nog op €16 gekomen.
Kijk eens naar Isodiol. + 30%
Karel-B schreef op 5 april 2018 08:54 :
[...]
Door telkens te verkopen en dan €1,20 lager terug te kopen en dat herhalen. Met die 20ct dekte ik de orderkosten af en die €1 ging dan af van mijn gemiddelde prijs per aandeel. Overigens is de koers gisteren nog op €16 gekomen.
sorry heb niet goed gelezen want heb zelf als op CAD staan en ja dat scheelt nogal wat met de EURO, maar dan toch knap om dat gemiddelde zover omlaag te halen. zelf zit ik er veel te hoog in maar we wachten af op die dagen van +15% of meer
eri09 schreef op 5 april 2018 12:53 :
[...]
sorry heb niet goed gelezen want heb zelf als op CAD staan en ja dat scheelt nogal wat met de EURO, maar dan toch knap om dat gemiddelde zover omlaag te halen.
zelf zit ik er veel te hoog in maar we wachten af op die dagen van +15% of meer
Ik heb dat tot nu toe 3x gedaan, ik had nog veel meer verlies dan jij (in verhouding) dus het is mogelijk. Ik ga er nu ook gewoon mee door en zodra ik de kans krijg bij Aurora en Aphria doe ik het daar ook. Ik sta nu voor het eerst positief met een cannabis aandeel (Canopy).
staan in het groen maar vindt het niet overtuigend ben toch bang dat we over een uur weer in de min gaan of ze moeten doorpakken en richting de +6-8% gaan
eri09 schreef op 5 april 2018 15:54 :
en daar gaan we al damm
Als je geen geduld hebt kan je beter stoppen met beleggen.
rider13 schreef op 5 april 2018 16:00 :
[...]
Als je geen geduld hebt kan je beter stoppen met beleggen.
Dat vindt ik ook... Het zal zo zeker nog doorgaan( véél volatiliteit) tot deze zomer als de goedkeuring er (niet) komt.
ben ik het ook mee eens, Aurora is voor de lange termijn ik ben ook te hoog ingestapt en sta 30% in de min, maar ik wacht het gewoon af, ga het iedergeval niet met verlies verkopen
Wat zijn jullie verwachtingen eigenlijk voor Aurora op lange termijn?
ho ho ik zit ook voor de lange termijn in Canopy, Aphria en Med. dus dat is het hem niet maar de laatste dagen is het zo dat de opgebouwde + in het eerste 1/2 uur en weer snel afgaat en dat we dan gewoon weer in de min duiken. valt me gewoon op dat dit de laatste weken echt veel gebeurt en weet niet waarom anders dan trump, china en canada zelf. gewoon een observatie over een vreemd dag verloop niets anders
iemand hier in Namaste Techn.?
ikketje88 schreef op 5 april 2018 16:32 :
Wat zijn jullie verwachtingen eigenlijk voor Aurora op lange termijn?
www.newswire.ca/news-releases/aurora-... gokje op koersdoel (na legalisatie) / CAN 15 - 12/2018 / CAN 30 - 06/2019 / CAN 40 - 12/2019.
Empros schreef op 5 april 2018 23:36 :
[...]
www.newswire.ca/news-releases/aurora-... gokje op koersdoel (na legalisatie) / CAN 15 - 12/2018 / CAN 30 - 06/2019 / CAN 40 - 12/2019.
Q2 ziet er heel goed uit Empros. Dat gokje kan nog wel bewaarheid worden. :)
er zijn veel interessante, het is de kunst om de juiste eruit te halen, aurora, aphria, canopy, emblem, organigram... welke zal het meest stijgen, iemand gokje? :)
VANCOUVER, British Columbia, Jan. 12, 2018 (GLOBE NEWSWIRE) -- Isodiol International Inc. (CSE:ISOL) (OTC:ISOLF) (FSE:LB6A.F) (the "Company" or "Isodiol"), a global bio-active phytoceutical innovator specializing in the development of pharmaceutical and wellness products, is pleased to announce that it has signed a binding agreement with Namaste Technologies Inc. ("Namaste") (CNSX:N) (OTCQB:NXTTF) (FRA:M5BQ), an online retailer for cannabis delivery systems globally. Through this non-exclusive partnership, Isodiol will become a provider of phytoceutical products to Namaste, to be sold through select distribution channels on its e-commerce platform. Namaste Technologies Inc. "The shopping habits of today's consumers are greatly steered towards e-commerce and we want our customers to have the same convenience and ease when shopping for cannabinoid products that they do with other items," said Marcos Agramont, CEO of Isodiol. "This partnership will be a great compliment to our current e-commerce platform as Namaste has expansive international distribution channels that will allow us to expand our product offerings on a global scale. We look forward to providing their consumers with safe, consistent and highly bio-active phytoceutical products." This agreement is mutually beneficial for both companies, as it offers a new domestic and international sales channel for Isodiol to distribute its products. In addition, this agreement adds significant value to Namaste's product offering on a global scale and through its wholly owned subsidiary, Cannmart Inc. ("Cannmart"), which is an Access to Cannabis for Medical Purposes ("ACMPR") applicant for a medical cannabis "sales-only" license. Namaste intends to offer Isodiol's innovative pharmaceutical-grade products to Cannmart patients and to distribute the products in regional markets where cannabinoid products are available. "This transaction further demonstrates our eagerness to attract industry leaders who see value and can benefit from our revolutionary e-commerce platform. We are very much looking forward to offering Isodiol's best in-class quality range of products through our sales channels, as we look to broaden our product offerings to encompass some of the most innovative phytoceutical products in the market," said Sean Dollinger, President and CEO of Namaste. "Namaste remains focused on becoming a global leader in the cannabis space. We are extremely confident in our model and believe amalgamating the industry's most innovative products in one marketplace will revolutionize the cannabis industry. This partnership reaffirms the traction Namaste is gaining in the cannabis space, as our peers look to source out innovative platforms to distribute their products and grow their market share. We are extremely pleased to have partnered with Isodiol and look forward to launching their products through our marketplace in the near future."
NAMASTE ANNOUNCES SHARE PURCHASE AND MEDICAL CANNABIS LICENSED DEALER APPLICATION LETTER OF INTENT WITH 2624078 ONTARIO INC. Namaste Technologies Inc. has signed a non-binding letter of intent with 2624078 Ontario Inc., whereby Namaste would acquire 51 per cent of the share capital of 2624078 Ontario Inc., which will undertake an application to become a licensed dealer of medical cannabis, in accordance with Health Canada regulations. Licensed dealers are authorized to perform research and development, analytical testing and conducting clinical studies with medical cannabis, as well as importing medical cannabis for research purposes. The location for the licensed dealer facility is at 7 Canso Rd. in Etobicoke, Ont., and directly across the street from the Access to Cannabis for Medical Purposes (ACMPR) facility of Namaste's wholly owned subsidiary, Cannmart Inc. The purpose of Namaste's investment and partnership with 2624078 Ontario is to facilitate research and development of medical cannabis extracts as well as for testing of imported medical cannabis products in accordance with ACMPR guidelines. Namaste's partnership with 2624078 Ontario reinforces Namaste's position as a leader in the medical cannabis industry and helps ensure that it will be a first mover in the research and production of cannabis concentrates as it anticipates a growing demand for extracts in the future. Key terms of the letter of intent: Namaste will acquire 51 per cent of the share capital of 2624078 Ontario. Namaste and will provide debt financing of up to $750,000 to complete construction of the licensed dealer facility. 2624078 Ontario's existing management team will sign three-year management agreements to provide operational oversight of the facility. Both parties will have 30 days from the date of execution of the letter of intent to negotiate terms of definitive documentation, which will include a share purchase agreement and management agreements. The facility at 7 Canso Rd. will be constructed to meet ACMPR standards. The letter of intent and proposed share purchase agreement represent a significant milestone for Namaste in securing a facility that will facilitate the importation of unique strains of medical cannabis for testing purposes, as well as research and production of high-potency cannabis extracts. If a licensed dealer licence is obtained, Namaste will be able to import medical cannabis from international partners for the purpose of testing the product against ACMPR standards. In addition to providing the ability to import medical cannabis for research purposes, the licensed dealer licence would also allow Namaste to begin research and development of medical cannabis extracts. Currently, the company estimates that cannabis extract sales in the United States represent over 50 per cent of all dispensary sales. As Namaste anticipates further expansion of Canada's legal medical cannabis platform, it expects to see significant industry trends toward these higher potency products. This letter of intent and the implications of obtaining a licensed dealer licence for Namaste would ensure the company's position in what it expects to become a strong segment of the Canadian medical cannabis industry in the future. Management commentary Daniel Stern, president and chief executive officer of 2624078 Ontario, commented: "We are very excited to be working with Namaste on this project. We believe that our experience in cannabis extraction technology and many years of experience in the general cannabis industry will facilitate the success of this partnership with Namaste, who we believe is a leading innovator in the Canadian medical cannabis community." Sean Dollinger, president and chief executive officer of Namaste, commented: "We are very pleased to have signed this letter of intent as we feel confident in the future of medical cannabis extracts in the Canadian marketplace. Although high-potency concentrates are not yet approved under ACMPR regulations, the LD licence will provide Namaste with the opportunity to take the first steps towards not only researching and producing extracts but also engage in the process of importing medical cannabis for testing purposes. The management team of 2624078 Ontario Inc. has shown confidence in Namaste's leadership abilities as demonstrated through our success in the industry to date. The launch of NamasteMD and our pending ACMPR sales licence coupled with this letter of intent and the application for an LD licence are important building blocks to solidify Namaste's position as a leader in the Canadian medical cannabis industry." About Namaste Technologies Inc. Namaste is the largest on-line retailer for medical cannabis delivery systems globally. Namaste distributes vaporizers and smoking accessories through 24 e-commerce sites in 20 countries, with distribution hubs located around the world. Namaste has majority market share in Europe and Australia, with operations in the United Kingdom, Canada and Germany, and it has opened new supply channels into emerging markets, including Brazil, Mexico and Chile. Namaste, through its acquisition of Cannmart, is pursuing a new revenue vertical in on-line retail of medical cannabis in the Canadian market. Namaste intends to leverage its existing database of Canadian cannabis consumers, along with its expertise in e-commerce, to create an on-line marketplace for medical cannabis patients, offering a larger variety of product and a better user experience.
Dit en de brede onderdelen van dit bedrijf die reeds winst of kunnen gaan genereren heeft mij helpen besluiten in Namaste Techn te stappen deze week. Dit kan een grote speler in de markt gaan worden en is nu een koopje mits alles volgens verwachtingen van de markt blijft verlopen
Aantal posts per pagina:
20
50
100
Direct naar Forum
-- Selecteer een forum --
Koffiekamer
Belastingzaken
Beleggingsfondsen
Beursspel
BioPharma
Daytraders
Garantieproducten
Opties
Technische Analyse
Technische Analyse Software
Vastgoed
Warrants
10 van Tak
4Energy Invest
Aalberts
AB InBev
Abionyx Pharma
Ablynx
ABN AMRO
ABO-Group
Acacia Pharma
Accell Group
Accentis
Accsys Technologies
ACCSYS TECHNOLOGIES PLC
Ackermans & van Haaren
ADMA Biologics
Adomos
AdUX
Adyen
Aedifica
Aegon
AFC Ajax
Affimed NV
ageas
Agfa-Gevaert
Ahold
Air France - KLM
Airspray
Akka Technologies
AkzoNobel
Alfen
Allfunds Group
Allfunds Group
Almunda Professionals (vh Novisource)
Alpha Pro Tech
Alphabet Inc.
Altice
Alumexx ((Voorheen Phelix (voorheen Inverko))
AM
Amarin Corporation
Amerikaanse aandelen
AMG
AMS
Amsterdam Commodities
AMT Holding
Anavex Life Sciences Corp
Antonov
Aperam
Apollo Alternative Assets
Apple
Arcadis
Arcelor Mittal
Archos
Arcona Property Fund
arGEN-X
Aroundtown SA
Arrowhead Research
Ascencio
ASIT biotech
ASMI
ASML
ASR Nederland
ATAI Life Sciences
Atenor Group
Athlon Group
Atrium European Real Estate
Auplata
Avantium
Axsome Therapeutics
Azelis Group
Azerion
B&S Group
Baan
Ballast Nedam
BALTA GROUP N.V.
BAM Groep
Banco de Sabadell
Banimmo A
Barco
Barrick Gold
BASF SE
Basic-Fit
Basilix
Batenburg Beheer
BE Semiconductor
Beaulieulaan
Befimmo
Bekaert
Belgische aandelen
Beluga
Beter Bed
Bever
Binck
Biocartis
Biophytis
Biosynex
Biotalys
Bitcoin en andere cryptocurrencies
bluebird bio
Blydenstijn-Willink
BMW
BNP Paribas S.A.
Boeing Company
Bols (Lucas Bols N.V.)
Bone Therapeutics
Borr Drilling
Boskalis
BP PLC
bpost
Brand Funding
Brederode
Brill
Bristol-Myers Squibb
Brunel
C/Tac
Campine
Canadese aandelen
Care Property Invest
Carmila
Carrefour
Cate, ten
CECONOMY
Celyad
CFD's
CFE
CGG
Chinese aandelen
Cibox Interactive
Citygroup
Claranova
CM.com
Co.Br.Ha.
Coca-Cola European Partners
Cofinimmo
Cognosec
Colruyt
Commerzbank
Compagnie des Alpes
Compagnie du Bois Sauvage
Connect Group
Continental AG
Corbion
Core Labs
Corporate Express
Corus
Crescent (voorheen Option)
Crown van Gelder
Crucell
CTP
Curetis
CV-meter
Cyber Security 1 AB
Cybergun
D'Ieteren
D.E Master Blenders 1753
Deceuninck
Delta Lloyd
DEME
Deutsche Cannabis
DEUTSCHE POST AG
Dexia
DGB Group
DIA
Diegem Kennedy
Distri-Land Certificate
DNC
Dockwise
DPA Flex Group
Draka Holding
DSC2
DSM
Duitse aandelen
Dutch Star Companies ONE
Duurzaam Beleggen
DVRG
Ease2pay
Ebusco
Eckert-Ziegler
Econocom Group
Econosto
Edelmetalen
Ekopak
Elastic N.V.
Elia
Endemol
Energie
Energiekontor
Engie
Envipco
Erasmus Beursspel
Eriks
Esperite (voorheen Cryo Save)
EUR/USD
Eurobio
Eurocastle
Eurocommercial Properties
Euronav
Euronext
Euronext
Euronext.liffe Optiecompetitie
Europcar Mobility Group
Europlasma
EVC
EVS Broadcast Equipment
Exact
Exmar
Exor
Facebook
Fagron
Fastned
Fingerprint Cards AB
First Solar Inc
FlatexDeGiro
Floridienne
Flow Traders
Fluxys Belgium D
FNG (voorheen DICO International)
Fondsmanager Gezocht
ForFarmers
Fountain
Frans Maas
Franse aandelen
FuelCell Energy
Fugro
Futures
FX, Forex, foreign exchange market, valutamarkt
Galapagos
Gamma
Gaussin
GBL
Gemalto
General Electric
Genfit
Genmab
GeoJunxion
Getronics
Gilead Sciences
Gimv
Global Graphics
Goud
GrandVision
Great Panther Mining
Greenyard
Grolsch
Grondstoffen
Grontmij
Guru
Hagemeyer
HAL
Hamon Groep
Hedge funds: Haaien of helden?
Heijmans
Heineken
Hello Fresh
HES Beheer
Hitt
Holland Colours
Homburg Invest
Home Invest Belgium
Hoop Effektenbank, v.d.
Hunter Douglas
Hydratec Industries (v/h Nyloplast)
HyGear (NPEX effectenbeurs)
HYLORIS
Hypotheken
IBA
ICT Automatisering
Iep Invest (voorheen Punch International)
Ierse aandelen
IEX Group
IEX.nl Sparen
IMCD
Immo Moury
Immobel
Imtech
ING Groep
Innoconcepts
InPost
Insmed Incorporated (INSM)
IntegraGen
Intel
Intertrust
Intervest Offices & Warehouses
Intrasense
InVivo Therapeutics Holdings Corp (NVIV)
Isotis
JDE PEET'S
Jensen-Group
Jetix Europe
Johnson & Johnson
Just Eat Takeaway
Kardan
Kas Bank
KBC Ancora
KBC Groep
Kendrion
Keyware Technologies
Kiadis Pharma
Kinepolis Group
KKO International
Klépierre
KPN
KPNQwest
KUKA AG
La Jolla Pharmaceutical
Lavide Holding (voorheen Qurius)
LBC
LBI International
Leasinvest
Logica
Lotus Bakeries
Macintosh Retail Group
Majorel
Marel
Mastrad
Materialise NV
McGregor
MDxHealth
Mediq
Melexis
Merus Labs International
Merus NV
Microsoft
Miko
Mithra Pharmaceuticals
Montea
Moolen, van der
Mopoli
Morefield Group
Mota-Engil Africa
MotorK
Moury Construct
MTY Holdings (voorheen Alanheri)
Nationale Bank van België
Nationale Nederlanden
NBZ
Nedap
Nedfield
Nedschroef
Nedsense Enterpr
Nel ASA
Neoen SA
Neopost
Neovacs
NEPI Rockcastle
Netflix
New Sources Energy
Neways Electronics
NewTree
NexTech AR Solutions
NIBC
Nieuwe Steen Investments
Nintendo
Nokia
Nokia OYJ
Nokia Oyj
Novacyt
NOVO-NORDISK AS
NPEX
NR21
Numico
Nutreco
Nvidia
NWE Nederlandse AM Hypotheek Bank
NX Filtration
NXP Semiconductors NV
Nyrstar
Nyxoah
Océ
OCI
Octoplus
Oil States International
Onconova Therapeutics
Ontex
Onward Medical
Onxeo SA
OpenTV
OpGen
Opinies - Tilburg Trading Club
Opportunty Investment Management
Orange Belgium
Oranjewoud
Ordina Beheer
Oud ForFarmers
Oxurion (vh ThromboGenics)
P&O Nedlloyd
PAVmed
Payton Planar Magnetics
Perpetuals, Steepeners
Pershing Square Holdings Ltd
Personalized Nursing Services
Pfizer
Pharco
Pharming
Pharnext
Philips
Picanol
Pieris Pharmaceuticals
Plug Power
Politiek
Porceleyne Fles
Portugese aandelen
PostNL
Priority Telecom
Prologis Euro Prop
ProQR Therapeutics
PROSIEBENSAT.1 MEDIA SE
Prosus
Proximus
Qrf
Qualcomm
Quest For Growth
Rabobank Certificaat
Randstad
Range Beleggen
Recticel
Reed Elsevier
Reesink
Refresco Gerber
Reibel
Relief therapeutics
Renewi
Rente en valuta
Resilux
Retail Estates
RoodMicrotec
Roularta Media
Royal Bank Of Scotland
Royal Dutch Shell
RTL Group
RTL Group
S&P 500
Samas Groep
Sapec
SBM Offshore
Scandinavische (Noorse, Zweedse, Deense, Finse) aandelen
Schuitema
Seagull
Sequana Medical
Shurgard
Siemens Gamesa
Sif Holding
Signify
Simac
Sioen Industries
Sipef
Sligro Food Group
SMA Solar technology
Smartphoto Group
Smit Internationale
Snowworld
SNS Fundcoach Beleggingsfondsen Competitie
SNS Reaal
SNS Small & Midcap Competitie
Sofina
Softimat
Solocal Group
Solvac
Solvay
Sopheon
Spadel
Sparen voor later
Spectra7 Microsystems
Spotify
Spyker N.V.
Stellantis
Stellantis
Stern
Stork
Sucraf A en B
Sunrun
Super de Boer
SVK (Scheerders van Kerchove)
Syensqo
Systeem Trading
Taiwan Semiconductor Manufacturing Company (TSMC)
Technicolor
Tele Atlas
Telegraaf Media
Telenet Groep Holding
Tencent Holdings Ltd
Tesla Motors Inc.
Tessenderlo Group
Tetragon Financial Group
Teva Pharmaceutical Industries
Texaf
Theon International
TherapeuticsMD
Thunderbird Resorts
TIE
Tigenix
Tikkurila
TINC
TITAN CEMENT INTERNATIONAL
TKH Group
TMC
TNT Express
TomTom
Transocean
Trigano
Tubize
Turbo's
Twilio
UCB
Umicore
Unibail-Rodamco
Unifiedpost
Unilever
Unilever
uniQure
Unit 4 Agresso
Univar
Universal Music Group
USG People
Vallourec
Value8
Value8 Cum Pref
Van de Velde
Van Lanschot
Vastned
Vastned Retail Belgium
Vedior
VendexKBB
VEON
Vermogensbeheer
Versatel
VESTAS WIND SYSTEMS
VGP
Via Net.Works
Viohalco
Vivendi
Vivoryon Therapeutics
VNU
VolkerWessels
Volkswagen
Volta Finance
Vonovia
Vopak
Warehouses
Wave Life Sciences Ltd
Wavin
WDP
Wegener
Weibo Corp
Wereldhave
Wereldhave Belgium
Wessanen
What's Cooking
Wolters Kluwer
X-FAB
Xebec
Xeikon
Xior
Yatra Capital Limited
Zalando
Zenitel
Zénobe Gramme
Ziggo
Zilver - Silver World Spot (USD)
Indices
AEX
865,35
-1,07%
EUR/USD
1,0677
+0,06%
FTSE 100
7.847,99
+0,35%
Germany40^
17.771,70
+0,01%
Gold spot
2.373,57
+0,53%
NY-Nasdaq Composite
15.683,37
-1,15%
Stijgers
Dalers